World leading supplier of innovative medical technology for patient monitoring
Since 1987, Compumedics’ strategy has focused on developing its core competency – Sleep Diagnostics – which has enabled the company to become one of the leaders in this growing international healthcare market. Today, Compumedics has evolved into one of the world’s leading suppliers of medical technology for sleep and neuro diagnostics (including brain research) and ultrasonic blood flow monitoring.
Compumedics’ technologies and products are distributed to clients around the globe, helping millions of people who suffer from debilitating sleep, neurological and other healthcare problems.
Compumedics is listed on the Australian Securities Exchange since 2000 – ASX: CMP.